🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06882577
Recruiting Observational

Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy

NCT06882577 · tracked via the Priya Life Science China tracker
Sponsor
Soochow University
Phase
Observational
Started
2025-03-31
Last updated
2025-05-13

Condition(s) studied

Acute Ischemic Stroke

Investigational drug(s) / intervention(s)

observational only- no intervention

observational only- no intervention: observational only- no intervention

Study summary

Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy.

This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Written informed consent by patient 2. Age ≥ 18 years 3. Acute ischemic stroke (with matching brain lesion on MR imaging) 4. Enrolment within 24 h after onset of stroke-related symptoms. Exclusion Criteria: 1. Pregnancy and / or breast-feeding. 2. Participation in an interventional study. 3. Patients refuse to participate in the research.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The first affiliated hospital of soochow university Suzhou Jiangsu Recruiting

More Soochow University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06882577 on ClinicalTrials.gov ↗ ← All trials in China